That quote you cited is what I'm referring to. I assume they mean they will re-evaluate existing drugs in the clinic as well and that the review is not just strictly related to pre-clinical R&D projects.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.